Viral Vector & Plasmid DNA Manufacturing Market Size, Trends, Growth, Share, Opportunities and Forecast by 2025

The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, according to a new report by Grand View Research, Inc., rising at a 16.0% CAGR during the forecast period. Rising number of gene therapy-based discovery programs in the pharma industry is one of the key trends driving the production of gene therapy vectors. Moreover, a robust pipeline of viral vaccines and gene therapies has prompted companies to develop novel and effective technologies for scalable manufacturing of vectors. Current vector manufacturing process is considered highly regulated, elaborate, and expensive.

Moreover, at present, there is a shortage of production sites to meet the demand by the pharmaceutical industry for vector construction services. These factors have created opportunities for companies to capitalize on potential avenues in the market through developing novel solutions.

Key growth strategies adopted by companies to sustain their market presence include continuous expansion of manufacturing sites in high-demand markets such as the U.S. and U.K. Moreover, companies are engaged in strategic mergers & facility acquisitions to meet growing requirements of viral vectors within the pharmaceutical and biotech industries and to broaden their service portfolios.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/viral-vector-manufacturing-market

Further Key Findings From the Report Suggest:

• Adenovirus and retrovirus were prominent vector type segments in the market in 2017. These can be produced at high titers and induce a strong humoral and, especially, a strong T cell response, as a result of which these vector type is extensively employed in vaccines
• Lentiviral production costs nearly up to 40.0% of the total cost of goods, thus inducing revenue growth in this vector type
• Downstream processing accounted for the largest share in 2017, owing to requirement of expensive equipment and skilled personnel for product recovery
• In terms of application, vector manufacturing for antisense, RNAi, & molecular therapy production represented the leading revenue share in 2017. This is due to high adoption rate of viruses for oligonucleotide and aptamers development in comparison to other applications
• The number of biotech companies that are engaged in employing vector for therapeutic production continue to increase over the period
• Recent approval of cancer gene therapy products encourages further efforts in this arena, thus resulting in the cancer segment holding the dominant revenue share
• North America led the global market owing to presence of several universities and research institutes that are engaged in genomic research programs
• Cobra Biologics, Merck, uniQure N.V., and Novasep are some key participants that are focusing towards capitalizing of untapped avenues in the market.

Grand View Research has segmented the global viral vector & plasmid DNA manufacturing market on the basis of vector type, workflow, application, end-use, disease, and region:

Viral Vector & Plasmid DNA Manufacturing Vector Type Outlook (Revenue, USD Million, 2014 - 2025)

• Adenovirus
• Retrovirus
• Plasmid DNA
• AAV
• Lentivirus
• Others

Viral Vector & Plasmid DNA Manufacturing Workflow Outlook (Revenue, USD Million, 2014 - 2025)

• Upstream Processing
  • Vector Amplification & Expansion
  • Vector Recovery/Harvesting
• Downstream Processing
  • Purification
  • Fill-finish

Nanomedicine Market Size, Trends, Growth, Share, Opportunities and Forecast by 2025

The global nanomedicine market is anticipated to reach USD 350.8 billion by 2025, according to a new report by Grand View Research, Inc. Development of novel nanotechnology-based drugs and therapies is driven by the need to develop therapies that have fewer side effects and that are more cost-effective than traditional therapies, in particular for cancer.

Application of nanotechnology-based contrast reagents for diagnosis and monitoring of the effects of drugs on an unprecedented short timescale is also attributive drive growth in the coming years. Additionally, demand for biodegradable implants with longer lifetimes that enable tissue restoration is anticipated to influence demand.

As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

Solutions such as nanoformulations with triggered release for tailor-made pharmacokinetics, nanoparticles for local control of tumor in combination with radiotherapy, and functionalized nanoparticles for targeted in-vivo activation of stem cell production are anticipated to drive R&D, consequently resulting in revenue generation in the coming years.

Biopharmaceutical and medical devices companies are actively engaged in development of novel products as demonstrated by the increasingly growing partnerships between leading enterprises and nanomedicine startups. For instance, in November 2015, Ablynx and Novo Nordisk signed a global collaboration and a licensing agreement for development and discovery of innovative drugs with multi-specific nanobodies. This strategic partnership is anticipated to rise the net annual sales of the products uplifting the market growth.

However, in contrary with the applications of nanotechnology, the entire process of lab to market approval is a tedious and expensive one with stringent regulatory evaluation involved thereby leading investors to remain hesitant for investments.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/nanomedicine-market

Further key findings from the report suggest:

• Therapeutics accounted for the largest share of market revenue in 2016 owing to presence of nanoemulsions, nanoformulations, or nanodevices
• These devices possess the ability to cross biological barriers. Moreover, presence of drugs such as Doxil, Abraxane, and Emend is attributive for higher revenue generation
• Presence of substantial number of products manufactured through the use of microbial sources can be attributed for the largest share
• In-vitro diagnostics is expected to witness lucrative progress as a result of R&D carried out in this segment
• Introduction of nano-enabled biomarkers, vectors and contrast agents with high-specificity and sensitivity are attributive for projected progress
• Clinical cardiology is expected to witness the fastest growth through to 2025 owing to development in nano-functionalization and modification of surfaces for increased biocompatibility of implants in treatment of late thrombosis
• Moreover, an abundance of research publications and patent filings from European region with a share of about 25% in nanomedicine-related publications is supportive for revenue generation from European economies
• Asia Pacific is estimated to witness the fastest growth over the forecast period
• Factors responsible include government and regulatory authorities that have implemented a framework to encourage R&D collaborations and framework extension.
• Key players operating in this industry include Pfizer Inc., Ablynx NV, Nanotherapeutics Inc., Nanoviricides Inc., Abraxis Inc., Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, and Merck
• Active expansion strategies are undertaken by a number of the major market entities in order to strengthen their position

• North America dominated the industry in 2016, accounting for a 42% of total revenue
• Presence of key participants operating in the region are involved in collaborative activities are attributive for the largest share of North America in sector revenue

Grand View Research has segmented the nanomedicine market on the basis of product, application, nanomolecule type, and region:

Nanomedicine Product Outlook (Revenue, USD Billion; 2013 - 2025)

• Therapeutics
• Regenerative medicine
• In-vitro diagnostics
• In-vivo diagnostics
• Vaccines

Sustained Release Excipients Market Growth Analysis, Opportunities and Forecast by 2026

The global sustained release excipients market size is expected to reach USD 1.6 billion by 2026 at a 7.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Increasing focus on novel drug delivery R&D and rising adoption of extended release formulations for treatment of chronic diseases are major factors driving the market.

Use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits. Reduced dosage frequency, improved patient compliance, maintenance of constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness in the long run are some of the major advantages of using this technology.

Global rise in incidence of chronic and infectious diseases has also resulted in antibiotic resistance, which negatively affects the market for conventional dosage forms. Thus, alternative methods to manage and treat these diseases are being implemented. Use of sustained release formulations has been widely accepted among physicians in order to combat antibiotic resistance. Since these formulations create desired therapeutic drug levels in blood plasma and reduce dosage frequency, they are the preferred choice of formulation among physicians, which increases their demand.

To request a sample copy or view summary of this report, click the link below: 

www.grandviewresearch.com/industry-analysis/sustained-release-excipients-market

Further key findings from the report suggest:

• Polymers formed the largest revenue grossing segment by product type in 2017 and is anticipated to grow at a lucrative rate during the forecast period. This is due to its high adoption in sustained release formulations as they provide greater strength and improved shelf-life
• In terms of route of administration, the oral segment held the dominant share in 2017 and is projected to witness steady growth to retain its lead throughout the forecast period
• Transdermal technology is expected to exhibit the highest CAGR during the forecast period owing to its escalating usage. It minimizes various limitations associated with oral and parenteral route of administrations
• North America dominated the overall market in 2017 due to well-developed research infrastructure and presence of leading pharmaceutical and biopharmaceutical companies
• Asia Pacific is spearheading revenue growth, with Japan, China, and India at the forefront
• Some of the key companies in the market are Coating Place, Inc.; Depomed, Inc.; Corium International, Inc.; Capsugel; Aradigm Corporation; Orbis Biosciences, Inc.; and Alkermes plc.

Grand View Research has segmented the global sustained release excipients market on the basis of product, route of administration, technology, and region:

Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2015 - 2026)

• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Vaginal
• Ophthalmic
• Intravenous
• Others

Xylitol in Personal Care & Cosmetics Market Size, Trends, Growth, Share, Opportunities and Forecast by 2025

The global xylitol in personal care and cosmetics market size is expected to reach USD 48.8 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.0% over the forecast period. Increasing consumer awareness regarding the health benefits of xylitol in cosmetics and personal care products is likely to drive the market over the forecast period.
Rapid urbanization has resulted in a shift in buying behavior of consumers; for instance, the rising popularity of sugar-free chewing gum. Sugar-free gum, infused with xylitol can prevent dry mouth and tooth decay and it can improve overall oral health. Increasing consumption of sugar-free chewing gums is projected to propel the product demand over the forecast period.
Xylitol has gained popularity as an alternative sweetener and is considered to be a healthier option than sugar. Thus, it is mostly used as a sugar substitute, which is expected to witness growth as it accounts for lesser calories compared to conventional sugar. Its antimicrobial properties are also known to benefit the skin and hair. Rise in consumer health awareness is anticipated to drive the demand for products containing xylitol, which in turn, is anticipated to propel market growth.
Availability of a large number of substitutes is projected to act as a major restraining factor for xylitol in personal care and cosmetics market in near future. Sorbitol, isomalt, and mannitol are some of the significant xylitol alternatives available in the market. The choice of a substitute primarily depends on consumer acceptance, product cost, and end-use.
The market is reasonably consolidated with leading participants accounting for 40% of the total market share. Key companies focus on innovation and introduction of natural products keeping the changing demand pattern in mind.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/xylitol-in-personal-care-cosmetics-market

Further key findings from the report suggest:

• Global demand for xylitol in personal care and cosmetics market is anticipated to reach over 9,000 tons by 2025
• In terms of revenue, oral care segment is projected to ascend at the highest CAGR of over the forecast period
• Asia Pacific is anticipated to witness higher demand for the product over the forecast period owing to rapid urbanization, changing lifestyle, and consumer health consciousness
• Some of the major market participants are Roquette Freres SA; Croda International Plc; Xlear, Inc.; DuPont Nutrition and Health; Berner OY; and Chemyunion.

Grand View Research has segmented the global xylitol in personal care and cosmetics market on the basis of application and region:
Xylitol in Personal Care and Cosmetics Application Outlook (Volume, Tons; Revenue, USD Thousands, 2014 - 2025)

• Skin
• Hair
• Oral
  
  • Toothpaste
  • Mouth Wash
  • Others
• Others

Automotive Glass Market Growth Analysis, Opportunities and Forecast by 2025

The global automotive glass market size is anticipated to reach USD 21.72 billion by 2025 expanding at a CAGR of 5.7%, according to a new report by Grand View Research, Inc. Increasing automobile production across the globe on account of technological advancements and rising disposable income levels, especially in emerging countries like China, India, and Japan, will augment the product demand over the forecast period.
China, in particular, is the largest market due to its significant vehicle production, which was estimated at approximately 29 million units in 2017. As a result, Asia Pacific region is anticipated to hold the largest share of the global automotive glassmarket over the forecast period. Moreover, rising investments by international OEMs in the region due to factors like land and raw material availability, high domestic demand, and cheap labor cost will drive the regional market further. The passenger car segment is likely to have a high growth on account of development of advanced automotive glass products with high-end features.
In addition, consumers’ willingness to pay extra for premium passenger cars to get better quality and durability are likely to have a positive impact on the product demand. Laminated glasses are widely used in vehicle backlites as they offer lower visual distortion than other products, resulting in enhanced road safety. Furthermore, they can be easily repaired after damage unlike the tempered glass, which needs to be replaced completely.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/automotive-glass-market

Further key findings from the study suggest:

• Laminated glass segment held the highest revenue share of 55.1% in 2018 owing to various safety and value added features provided by the product
• Sunroof is anticipated to be the fastest-growing application segment over the forecast period due to increasing integration of sunroof systems in mid-segment cars
• OEM was the largest end-use segment in 2018 and is projected to maintain the dominance throughout the forecast years due to rising demand for passenger cars
• Central & South America is forecasted to register the fastest CAGR of 7.4% from 2019 to 2025 due to increasing vehicle production in the region. Passenger car production in CSA grew by 21.4% in 2017 in comparison to 2016
• Compagnie de Saint-Gobain S.A.; Asahi Glass Co. Ltd.; Fuyao Glass Industry Group Co., Ltd.; Nippon Sheet Glass Company, Ltd. (NSG); and Corning Inc. are some of the key companies in the market

Grand View Research has segmented the global automotive glass market on the basis of product, application, end use, vehicle type, and region:
Automotive Glass Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

• Tempered
• Laminated
• Others

Automotive Glass Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

• Windscreen
• Backlite
• Sidelite
• Sunroof

IVF Market Size, Trends, Growth, Share, Opportunities and Forecast by 2026

The global in-vitro fertilization market size is expected to reach USD 36.2 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.2% during the forecast period. The market is driven by the increasing incidence of infertility owing to lifestyle changes, government initiatives to provide better reimbursement policies, and the continuous efforts by the industry contributors. Expansion of fertility procedures for treating male infertility such as ICSI, is projected to positively influence the growth in near future.
Moreover, availability of genomic testing with the ability to prevent the transfer of genetic disease during IVF procedure is expected to drive the market. Increasing number of IVF treatments has encouraged more insurance providers to cover these procedures. This has ultimately led to competitive pricing and has moderated the treatment costs, driving the market with more treatment standardization and automation.
The behavioral shift in the society is the major factor contributing to the decreased Total Fertility Rate (TFR). This shift reflects on increasing number of working women, advanced maternal age, a shift from rural to urban societies, lower marriage rates, and delaying marriages. Such factors are projected to drive the in-vitro fertilization market during the forecast period.
Obesity is another factor leading to an increase in infertility. The fat deposited on women’s abdomen prevents follicular stimulation and produces male hormones. In case of males, rising fat deposits decrease testosterone levels and can result in lowered sperm production. Doctors recommend weight loss in men prior to fertility treatments along with proper maintenance of Body Mass Index (BMI). The U.S. Endocrine Society has established the use of Letrozole to increase the testosterone levels in obese patients.
The presence of favorable reimbursement framework, such as implementation of USD 50 million 5-year plans by the U.S Department of Defense for sperm/egg freezing coverage, is expected to drive the regional growth over the next six years. Increasing number of clinics undertaking newer techniques to offer better fertility success rates is also expected to boost the regional demand.
In Europe, the NHS covers three IVF cycles and provides coverage for gametes freezing. Moreover, the region is an attraction for international clients as countries, as countries such as Spain, have the highest number of egg donors. The clinics also provide sex identification and other IVF treatments, which are not offered in North America.
The Asia Pacific Initiative on Reproduction (ASPIRE) consists of a task force of clinicians and scientists involved in monitoring and managing fertility and Assisted Reproductive Technology (ART). Such initiatives promote awareness levels among consumers thereby, driving the growth of the IVF market.
Industry contributors are introducing advanced automation to shift the IVF treatment from invasive to minimally invasive or non-invasive procedure. The industry players are also working on technologies, which can enable older women to have enhanced fertility rates. In August 2015, OvaScience announced the results of its first published analysis comparing AUGMENT fertility treatment with a standard IVF. The results showed a significantly higher rate of selection and transfer of embryos as compared to the standard treatment.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market

Further key findings from the study suggest:

• Culture media led the overall market in terms of revenue in 2018. With the increasing government funding and industrial support for employees for egg/sperm freezing, the demand for cryopreservation and the required media for it, is expected to witness growth
• Increasing number of egg/sperm donor banks is expected to drive the demand for sperm, egg, and embryo processing media during the forecast period
• Fresh non-donor segment led the market in 2018. According to the 2003 - 2012 trends by the CDC, the number of fresh non-donors banking the eggs/embryos has drastically increased in U.S
• Europe led the in-vitro fertilization procedure and instrument market in 2018. High quality of treatment at economical prices and the adherence to medical standards have contributed to its market leadership
• North America also accounted for a significant market share in 2018. The standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and industry players introducing more IVF treatments are some contributing factors for the regional growth
• The demand for IVF treatment is expected to boom in APAC owing to fertility tourism and increasing penetration and awareness regarding the treatment in the developing economies
• Some key players in the In-vitro Fertilization (IVF) market include EMD Serono Inc.; Boston IVF; OvaScience; Thermo Fisher Scientific Inc.; Vitrolife AB; Irvine Scientific; CooperSurgical, Inc.; Cook Medical Inc.; Genea Biomedx; and Progyny Inc.

Grand View Research has segmented the global In-Vitro Fertilization (IVF) market by type, instrument, end use, and region:
In-Vitro Fertilization (IVF) Instrument Outlook (Revenue, USD Million, 2015 - 2026)

• Disposable Devices
• Culture Media
• Capital Equipment

In-Vitro Fertilization (IVF) Type Outlook (Revenue, USD Million, 2015 - 2026)

• Fresh Non-donor
• Frozen Non-donor
• Fresh Donor
• Frozen Donor

Personalized Retail Nutrition & Wellness Market Size, Trends, Growth, Share, Opportunities and Forecast by 2025

The global personalized retail nutrition & wellness market size is expected to reach USD 50.0 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 9.1% CAGR over the forecast period. Increase in demand for preventive health measures, rising trend for customization in the food sector, focus on healthier eating, and rising ongoing activities in nutrigenomics have strengthened the development of personalized nutrition products.

Concerns with respect to healthy lifestyle in order to gain optimum nutrition and preventing various illnesses is rising among the public. Factors pronouncing such concerns include inadequate nutrition in daily diet and sedentary lifestyle.

Currently, substantial marketed products are being produced and provided by startup companies such as STYR, Food Marbel, and Habit Food Personalized, LLC. Introduction of artificial intelligence-based algorithms to better track health data on routine basis has prompted medium-sized as well as well-established food and soft drink manufactures to design and develop various customized programs for people’s health and well-being.

To request a sample copy or view summary of this report, click the link below: 
www.grandviewresearch.com/industry-analysis/personalized-retail-nutrition-wellness-market

Further key findings from the report suggest:

• Based on product type, the market is bifurcated into dietary supplements & nutraceuticals and functional foods. Dietary supplements & nutraceuticals is projected to be the fastest growing segment owing to rising concern among people about lack of nutrition in their diet
• Vitamin dietary supplements held the largest share over other supplements owing to high market penetration of products in this segment. A major percentage of the U.S. population consume dietary intakes of vitamin A, C, D, and E
• The functional food products segment is fueled by easy availability of fortified products and changes in regulatory structure. Functional foods for protein source dominated the overall market owing to high usage rate of protein-enriched foods among athletes
• With respect to region, North America is estimated to emerge as the leading market in terms of revenue. This is primarily due to well-established food and biotechnology industries in U.S., coupled with presence of several personalized nutrition companies in the country
• Habit Food Personalized, LLC; Nima Labs, Inc.; Pfizer, Inc.; and Bayer AG are some key companies operating in this market. These players are focused on research activities for customized wellness product development.

Grand View Research has segmented the global personalized retail nutrition & wellness market on the basis of product type and region:

Personalized Retail Nutrition & Wellness Product Type Outlook (Revenue, USD Million, 2014 - 2025)

• Dietary Supplements & Nutraceuticals
  • Vitamins
  • Proteins
  • Minerals
  • Amino Acids
  • Enzymes
  • Others
• Functional Foods
  • Proteins
  • Vitamins
  • Dietary Fibers
  • Fatty Acids
  • Minerals
  • Prebiotics & Probiotics
  • Carotenoids

Histology & Cytology Market Shares, Growth and Opportunities Forecasts, 2025: Grand View Research, Inc.

The global histology and cytology market size is expected to reach USD 30.6 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 13.7% during the forecast period. Increasing incidence of cancer coupled with growing adoption of cytological test due to its high reliability and less invasive nature as compared to biopsy is likely to drive the growth.

Furthermore, rising number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect market growth. Advancements in cytology and histology save the time for pathologists, making the service more cost-effective.

Technological advancements and launch of new products are the high impact rendering drivers for the histology and cytology market. In March 2018, Roche launched VENTANA DP 200 slide scanner. It is a high-speed slide scanner for digital pathology. The scanner reduces workflow errors and improves image quality. In March 2016, Becton, Dickinson and Company received approval from the U.S. FDA for its automated cervical cancer screening systems, namely BD Totalys MultiProcessor and BD Totalys SlidePrep. These instruments are used for gynecological specimen preparation.

In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves detection of cervical precancer. In March 2018, BD Life Sciences-Diagnostic Systems launched BD SurePath, a liquid-based cytology test in India for screening and detection of cervical cancer, precancerous lesions, and other cytological categories.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/histology-and-cytology-market

Further key findings from the study suggest:

• Cytology testing led the market in 2018, attributed to high disease prevalence and adoption of the test for cervix screening. The segment is expected to maintain its position during the forecast period due to the recent entry of various tests and advantages over histology such as faster analysis and cost-effectiveness
• The U.S. histology and cytology market was the largest in 2018 and is expected to maintain its dominance during the forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries
• Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and adoption of screening tests
• Some of the key players operating in the market are Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.

Grand View Research has segmented the global histology and cytology market by type of examination and region:

Histology and Cytology Type of Examination Outlook (Revenue, USD Million, 2015 - 2026)

• Cytology
  • Cervical Cancer
  • Breast Cancer
  • Other Cancers
• Histology

Virtual Prototype (VP) Market Size, Trends, Growth, Share, Opportunities and Forecast by 2025

The global virtual prototype market size is estimated to reach USD 861.7 million by 2025, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 19.4% over the forecast period. Virtual prototyping tools enable faster product development, cost savings, and reduction in time to market.

These benefits are driving the development and adoption of VP tools. Enterprises/industrial manufacturers are switching to VP from conventional physical testing of product models. Physical testing consumed additional time and incurred high costs in the event of failure. Virtual prototype solutions enable organizations to significantly improve the accuracy of product testing and to enhance ergonomics and usability. This factor is driving growth of the global virtual prototype market.

Furthermore, increasing adoption of consumer electronic products such as smartphones, tablets, printers, and home appliances is encouraging manufacturers to deploy virtual prototyping tools to meet the overall production demand. It is also encouraging them to introduce innovative products to compete with other market players and to enhance profitability. All these factors are anticipated to further propel expansion of the global market over the forecast period.

Virtual prototyping is a software-based engineering process that helps build, simulate, and test a prototype virtually by simulating real-world conditions. The integration of technologies such as Computer-Aided Design (CAD), simulation tools, and Virtual Reality (VR) into VP tools has enabled manufacturers to increase product affordability. Moreover, virtual prototype simulation also aids in efficient planning of production lines and factory layouts.

Virtual prototyping solutions have a significant demand from the healthcare sector where they are used for pre-operative planning and surgical simulation. The growth of construction industry is also anticipated to drive the market for virtual prototype over the forecast period owing to rising demand for design simulation of buildings and plants. Asia Pacific has the largest concentration of consumer electronics manufacturers. Evolving consumer trends encourage manufacturers to innovate and develop novel products, which is anticipated to spur the market growth. Moreover, high investments in R&D to develop innovative virtual prototype tools such as CAD tools for live simulation, error-free production, and cost reduction during manufacturing are expected to further propel the global virtual prototype market growth.

To request a sample copy or view summary of this report, click the link below: 

www.grandviewresearch.com/industry-analysis/virtual-prototype-market

Further key findings from the study suggest:

• North America held the largest market share in 2017, owing to high adoption from automotive, electronics, and telecom industries to enhance overall operational efficiency and to improve customer satisfaction through iterative product releases
• Asia Pacific is expected to witness robust growth in the global virtual prototype market owing to rapid growth of regional automotive, aviation, and consumer electronics industries
• Adoption of cloud-based virtual prototype tools is projected to witness growth over the forecast period due to high demand from small- and medium-scale companies aiming to curb implementation and infrastructure costs
• Key automobile manufacturers such as BMW, Mercedes, and Volkswagen among others utilize VP tools to design and test new vehicle models. Emergence of advanced vehicular technologies and growing adoption of Electric Vehicles (EV) are anticipated to further promote market growth
• Some of the key market players are Autodesk, Inc.; TWI Ltd.; Synopsys, Inc.; ESI Group; Carbon Design Systems Inc.; Cadence Design Systems, Inc.; Siemens PLM Software; and PTC.

Radio Frequency Components Market Growth, Share, Opportunities and Forecast by 2022 | Key Industry Players International Quantum Epitaxy Plc

The global Radio Frequency (RF) components market is expected to reach USD 17.54 billion by 2022, according to a new study by Grand View Research, Inc. Growing adoption of consumer electronics including smartphones, tablets, notebooks, set top boxes and smart televisions is estimated to fuel industry growth over the next few years. Rising consumer disposable income particularly in developing countries like India and Brazil pared with overall improvement in global economy may elevate demand significantly. Technological advancements in the field of wireless communication and development in materials used for manufacturing RF components such as Silicon Germanium (SiGe) and Gallium Arsenide (GaAs) is also expected to drive industry growth.
Increasing popularity and adoption of high speed networks such as 3G and 4G have significantly impacted demand for RF components. Technological advancement enhancing antenna efficiency by replacing traditional filters with advanced tunable filter may escalate demand over the next seven years. The industry is poised for growth owing to increasing demand across automotive industry. Increasing efforts for development of advanced and innovative wireless infrastructure may also propel product demand.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/radio-frequency-rf-components-market

Further key findings from the study suggest:

• Power amplifiers segment accounted for over 30% of the overall share in 2014, which is expected to increase over the next few years owing to increasing prevalence of mixed-mode 3G/4G handsets coupled with growing emphasis on LTE concept.
• Antenna switches is estimated to exhibit rapid growth over the coming years, which may be primarily attributed to increasing experimentation with switch architectures particularly in higher end handsets. Growing number of 3G/4G handsets is anticipated to broadly contribute to this rapid growth.
• Consumer electronics segment accounted for more than 60% of the global revenue in 2014, which is estimated to increase over the coming years owing to rising consumer disposable income resulting in increasing adoption of consumer electronic products. Increasing consumer spending for smartphone, tablets and other portable electronic devices may spur demand.
• North America accounted for over 30% of the global revenue in 2014. Increasing demand for better mobility solutions is estimated to drive regional market growth. Asia Pacific RF components market is estimated to exhibit dramatic growth over the coming years attributing to increasing adoption of improved connectivity solutions in the region.
• Key players in this industry include Avago Technologies Ltd., Aixtron SE, NXP Semiconductors, RF Axis, STMicroelectronics, Texas Instruments, Renesas Electronics Corporation, Fujitsu Limited, and Freescale Semiconductor Inc. Industry participants compete on the basis of development of components that offer faster access to mobile data, high performance, cost and flexibility to support the corresponding solution.

Grand View Research has segmented the global radio frequency components market on the basis of product, application and region:
RF Components Product Outlook (Revenue, USD Million, 2012 - 2022)

• Filters
• Duplexer
• Power amplifiers
• Antenna switches
• Modulators & demodulators

RF Components Application Outlook (Revenue, USD Million, 2012 - 2022)

• Consumer electronics
  
  • Mobile phones
  • Tablets
  • Smart TVs & set top boxes
  • Laptops & notebooks
• Automotive
• Military
• Wireless communication

Liquid Synthetic Rubber Market Growth Analysis, Opportunities and Forecast by 2025

The global liquid synthetic rubber market size is expected to reach USD 5.02 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 4.6% during the forecast period. Growing demand for liquid isoprene, butadiene, and styrene butadiene rubber in tire manufacturing is expected to drive the growth in the forthcoming years.
High cost, low abrasion resistance, limited supply leading to price volatility of natural rubber has led to the increasing demand for synthetic rubber from application industries. In addition, these rubbers have inherent advantage in terms of physical properties, which is the primary factor driving the market.
Ascending demand for the product for adhesives, sealants, and coatings applications, on account of its excellent low-temperature profile, low Volatile Organic Compounds (VOC), and high electrical resistance is expected to complement market growth. In addition, rising demand for UV curable isoprene rubber as precision adhesive for electronics is expected to propel growth of the Liquid Synthetic Rubber (LSR) market.
The growing demand for products with low VOC concentration in polymer modifications and Ethylene Propylene Diene Monomer (EPDM) compounds to improve mechanical resistance and crosslink density is expected to increase product demand. Furthermore, increasing product penetration in polymer modifications to enhance functionality and durability is expected to drive the liquid synthetic rubber market.
Regulations pertaining to tire labeling compel tire manufacturers to label tires for key parameters, such as rolling resistance and wet grip. The European Union (EU) countries along with the U.S., China, and Japan, have implemented tire labeling regulations, which has a significant impact on the product manufacturing to improve the performance of the materials.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/liquid-synthetic-rubber-market

Further key findings from the report suggest:

• Butadiene accounted for 66.6% of the revenue share in 2017 on account of increasing penetration of the product in manufacturing sidewalls of truck and car tires as it aids in improving fatigue
• Adhesives, sealants & coatings application accounted for 54.8% of the isoprene segment in terms of revenue in 2017 on account of their excellent low-temperature profile, low VOC, and high electrical resistance
• Asia Pacific is expected to register a CAGR of 4.2% owing to the presence of major liquid synthetic rubber producers, availability of raw materials, low manufacturing cost, and increasing application scope
• U.S. accounted for 83.24% of North America’s revenue share on account of the presence of robust tire manufacturing and retreading sector along with the recovery of the country’s automotive industry
• The global liquid synthetic rubber market is niche and fragmented with very few manufacturers and service providers who compete on the basis of product quality improvement and capacity expansion.

Grand View Research has segmented the global liquid synthetic rubber market on the basis of product by application and region:
Liquid Isoprene Rubber Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Adhesive
• Sealants & coatings
• Industrial Rubber components
• Tire manufacturing
• Others

Liquid Butadiene Rubber Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Industrial rubber manufacturing
• Polymer modification
• Tire manufacturing
• Others

Metagenomics Market Growth, Share, Opportunities and Forecast by 2025

The global metagenomics market size is expected to reach USD 1.40 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 16.6% during the forecast period. Rise in demand for microbial screening in food and chemical industries for commercial applications, coupled with rapid developments in bioinformatics and biotechnology tools, is anticipated to accelerate market growth in the coming years.
Key market participants are striving to capitalize potential avenues in the market by addressing challenges faced by research entities pertaining to data assembly, identification, and verification of rare metagenomes. Furthermore, companies operating in the molecular diagnostics and genomics arena are a playing crucial role in this market by partnering with metagenomics companies for development of novel tests for disease diagnosis.
For instance, in September 2017, IDbyDNA, Inc. and ARUP Laboratories co-developed Explify Respiratory-a metagenomic NGS test for screening of respiratory infections. The anticipated launch of many such novel tests is projected to boost the market during the forecast period.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/metagenomics-market

Further key findings from the report suggest:

• Kits and reagents formed the largest segment by product in 2017 owing to frequent usage at various steps in microbial genomic studies
• Surplus growth in genomics database with respect to types and numbers has led to rising demand for better data analysis solutions. As a result, the sequencing and data analytics services segment is expected to emerge as a lucrative source of revenue generation during the forecast period
• Function driven technology held the major revenue share in 2017. Development of new screening procedures that facilitate rapid screening of large clone libraries has enabledfunctional detection of novel enzymes from metagenomes
• Advancements in genetic tools have broadened the application scope of metagenomics to include targeting microbes responsible for inducing various cancer forms. This, in turn, is driving the application of metagenomic analysis in human health
• North America dominated the market in 2017. Strong presence of key NGS leaders like Illumina and a substantial number of ongoing genomics-related studies in U.S. are major factors contributing to its large share
• Some of the key competitors in the market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup
• Acquisition of small players with a strong product portfolio is a prominently adopted strategy by dominant players. For instance, in August 2016, PerkinElmer acquired Bioo Scientific Corporation-provider of 16S & 18S library preparation kits for metagenome studies
• Competitors are also involved in collaborations with bioinformatics companies for co-development of novel platforms for metagenomics analysis.

Grand View Research has segmented the global metagenomics market on the basis of product, technology, application, and region:
Metagenomics Product Outlook (Revenue, USD Million, 2014 - 2025)

• Kits & Reagents
• Sequencing & Data Analytics Services
• Others

Metagenomics Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Sequencing Driven
• Function Driven

Metagenomics Application Outlook (Revenue, USD Million, 2014 - 2025)

• Environmental
• Human Health
• Others

Smart Packaging Market Industry Size, Share, Opportunities and Forecast by 2025: Grand View Research, Inc.

The global smart packaging market is expected to reach USD 26.7 billion by 2024, according to a new report by Grand View Research, Inc. Rising need for smart packaging products owing to increasing usage in the end use industries such as electronics and automotive on account of its superior protection properties is expected to fuel the growth over the forecast period. Rising industrialization in emerging regions including Asia Pacific and the Middle East is expected to drive the industry over the next eight years.
Increasing application scope in the logistics industry pertaining to the surging use of RFID tags at multiple levels to speed up locating products, and to improve the availability of real-time information coupled with the elimination of record loss is expected to drive the demand over the next eight years. Moreover, rising investment to improve the logistics industry within emerging economies such as China and India are projected to propel the industry growth.
Active Packaging accounted for over 70% of the market in terms of revenue on account of superior corrosion and moisture control properties. Growing use of the product in the automotive sector is likely to drive the demand over the forecast period.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/smart-packaging-market

Further key findings from the report suggest:

• The global smart packaging industry in terms of revenue was USD 10.8 Billion in 2015 and is expected to reach USD 26.7 Billion by 2024, recording a CAGR of 10.6% from 2016 to 2024.
• NFC (near field communication) is projected to be the fastest growing segment within intelligent packaging registering a CAGR of over 12% from 2016 to 2024. Usage of NFC in the telecom industries is rising exponentially. Smartphones equipped with NFC which can be paired with NFC tags or stickers, programmed by NFC apps to automate tasks and hence, is likely to fuel the growth of smart packaging market over the forecast period.
• Personal care sector is expected to register a CAGR of over 10% from 2016 to 2024 accounting for about 9% of the total market in 2015. Growing demand for personal care products particularly organic products on account of rising awareness about various health benefits over their synthetic counterparts is likely to fuel the industry over the forecast period.
• Automotive segment held a significant share of over 10% in 2015. The industry is expected to grow at a CAGR of around 12% from 2016 to 2024. Growing use of RFID tags in the automotive industry to improve the production efficiency is expected to drive the demand over the forecast period. Also, rising use of RFID tags in the automotive industry for asset tracking and supply chain management is expected to propel the industry growth.
•  Asia Pacific accounted for a significant share of over 11% in 2015. The ready availability of raw materials coupled with cheaper manufacturing costs is expected to drive the growth. The region is also projected to witness growth of over 14% from 2016 to 2024.
• The industry is moderately fragmented with the presence of a large number of prominent participants across the globe. Some leading companies operating in the global market include 3M, BASF, Du Pont, Avery Dennison Corp., Amcor Limited, Sealed Air Corporation and International Paper. 3M is an American company involved in product development, manufacturing, and marketing for businesses including industrial, safety & graphics, electronics & energy, healthcare, and consumer. The company manufactures a wide range of products which includes abrasives, maintenance, automotive, materials, films, hand hygiene, home improvement, components, patient monitoring, personal safety, signs & displays, filtration, surgical solutions, wire & cable and tapes & adhesives.

Grand View Research has segmented the smart packaging market by product, application, and region.
Global Smart Packaging Product Outlook (Revenue, USD Million, 2013 - 2024)

• Active Packaging
  
  • Gas Scavenger
  • Corrosion Control Packaging
  • Moisture Control Packaging
• Intelligent Packaging
  
  • Time temperature Indicator
  • Gas Indicator
  • Thermochromic Ink
  • RFID & Barcode
  • NFC